Istituto Nazionale dei Tumori, Milan at ENA 2026
Nov 18–20, 2026 Barcelona, Spain ~1.5k attendees Website
Istituto Nazionale dei Tumori, Milan brings 2 presentations to ENA 2026 in Barcelona. Its program centres on drug resistance in epithelioid sarcoma and breast cancer. It shows that histone deacetylase activity limits response to EZH2 inhibition in epithelioid sarcoma and can be targeted with an epigenetic combination, and covers the role of the extracellular matrix in breast cancer progression.
| Organization | ENA 2026 Attendance |
|---|---|
Istituto Nazionale dei Tumori, Milan Milan, Italy | |
Public cancer hospital and research institute (IRCCS). | Poster Wed Nov 18 12–1:30pm 3:50–4:15pm 5:45–7pm Talk Thu Nov 19 5:20–5:40pm |
Instantly find 20 buyers from Istituto Nazionale dei Tumori, Milan
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by EORTC, the NCI or the AACR. Submit a correction